» Authors » Nada Suvajdzic-Vukovic

Nada Suvajdzic-Vukovic

Explore the profile of Nada Suvajdzic-Vukovic including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 83
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kozarac S, Ivanovic J, Mitrovic M, Tomic Vujovic K, Arsenovic I, Suvajdzic-Vukovic N, et al.
Front Pharmacol . 2025 Jan; 15():1517972. PMID: 39830358
The treatment of chronic lymphocytic leukemia (CLL) consists of the continuous use of Bruton tyrosine kinase inhibitors (BTKis) such as ibrutinib, acalabrutinib, zanubrutinib and pirtobrutinib, or Bcl-2 inhibitors, such as...
2.
Pravdic Z, Suvajdzic-Vukovic N, Virijevic M, Mitrovic M, Pantic N, Sabljic N, et al.
J Med Biochem . 2024 Aug; 43(4):545-555. PMID: 39139169
Background: Cytarabine-anthracycline-based induction chemotherapy remains the standard of care for remission induction among patients with newly diagnosed acute myeloid leukaemia (AML). There are remarkable differences in therapy response among AML...
3.
Mitrovic M, Pantic N, Bukumiric Z, Sabljic N, Virijevic M, Pravdic Z, et al.
Thromb J . 2024 Apr; 22(1):37. PMID: 38632595
Background: Patients with acute myeloid leukemia (AML) are at increased risk of venous thromboembolic events (VTE). However, thromboprophylaxis is largely underused. Objectives: This study aimed to determine possible VTE development...
4.
Pantic N, Cvetkovic M, Milin-Lazovic J, Vukmirovic J, Pavlovic A, Virijevic M, et al.
Vasc Med . 2024 Apr; 29(3):320-327. PMID: 38573108
Inferior vena cava (IVC) anomalies are uncommon congenital causes of deep vein thrombosis (DVT). KILT syndrome (kidney and IVC abnormalities with leg thrombosis) has only been described as case reports...
5.
Virijevic M, Kraguljac-Kurtovic N, Mitrovic M, Jakovic L, Bukumuric Z, Pantic N, et al.
Hematol Oncol . 2024 Mar; 42(2):e3253. PMID: 38536200
Examination of central nervous system (CNS) involvement is not routine diagnostic practice in adult patients with acute myeloid leukemia (AML). Therefore, many asymptomatic patients with CNS involvement might go undetected....
6.
Cvetkovic Z, Pantic N, Cvetkovic M, Virijevic M, Sabljic N, Marinkovic G, et al.
Diagnostics (Basel) . 2023 Sep; 13(18). PMID: 37761258
Autoimmune hemolytic anemia (AIHA) is a rare, very heterogeneous, and sometimes life-threatening acquired hematologic disease characterized by increased red blood cell (RBC) destruction by autoantibodies (autoAbs), either with or without...
7.
Cvetkovic M, Pantic N, Virijevic M, Pravdic Z, Sabljic N, Mitrovic M, et al.
J Infect Dev Ctries . 2023 Jul; 17(6):800-804. PMID: 37406068
Introduction: Coronavirus disease 2019 (COVID-19) vaccines are considered to be safe. Only few cases of vaccine-induced immune thrombocytopenia or immune hemolysis have been reported so far. Evans syndrome (ES) is...
8.
Mitrovic M, Pantic N, Sabljic N, Bukumiric Z, Virijevic M, Pravdic Z, et al.
Cancers (Basel) . 2023 Jun; 15(11). PMID: 37297022
Background: Patients with hematological malignancies have an increased risk of arterial thrombotic events (ATEs) after diagnosis, compared to matched controls without cancer. However, data about incidence and risk factors for...
9.
Pravdic Z, Suvajdzic-Vukovic N, Djurdjevic P, Pantic N, Bukumiric Z, Virijevic M, et al.
Eur J Haematol . 2023 Jan; 110(5):548-553. PMID: 36656555
Introduction: Thrombopoietin receptor agonists (TPO-RAs) increase platelet counts (PC) in the majority of patients with chronic immune thrombocytopaenia (ITP). Platelet kinetics study (PKS) might contribute to the understanding of mechanisms...
10.
Pantic N, Suvajdzic-Vukovic N, Virijevic M, Pravdic Z, Sabljic N, Adzic-Vukicevic T, et al.
Blood Coagul Fibrinolysis . 2021 Dec; 33(1):51-55. PMID: 34861655
There are limited data on the impact of severe acute respiratory syndrome corona virus 2 infection in patients previously diagnosed with primary immune thrombocytopenia (ITP) on thrombopoietin receptor agonist therapy...